Treatment Trial Evaluating Long Acting Insulin in Type 1 Diabetes
Completed · Phase 4
Conditions studied: Type 1 Diabetes
In brief
Patients with type 1 diabetes trained in multiple daily insulin injection were treated with two diffferent kinds of long acting insulin preparations. The two insulin preparations were glargine and ultralente insulin. Patients were randomized to receive one of the two insulin preparations for the first 4 months followed by the second preparation for a further four months. Short acting insulin used was the same during both periods. We found that glargine insulin was better than ultralente insulin in our study.
Key facts
- Study ID
- NCT00276393
- Run by
- Mayo Clinic
- People needed
- 22
- Starts
- 2002-07-01
- Expected to finish
- 2003-12-01
- Last updated by the study team
- 2011-05-23
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.